Log In
Print this Print this

CA 125II radioimmunoassay (CA 125ll Radioimmunoassay)

  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionCA 125ll radioimmunoassay to detect ovarian cancer
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect ovarian cancer; Detect residual ovarian carcinoma in patients who have undergone first-line therapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today